Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-20

FDA Approved: PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved Lupin's supplemental application for Pentazocine Hydrochloride and Naloxone Hydrochloride, updating the product's approval under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentazocine Hydrochloride and Naloxone Hydrochloride (Pentazocine Hydrochloride and Naloxone Hydrochloride)

Snippet

SUPPL AP for PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE)